Literature DB >> 12407109

The protein kinase C beta II exon confers mRNA instability in the presence of high glucose concentrations.

Niketa A Patel1, Duane C Eichler, David S Chappell, Philip A Illingworth, Charles E Chalfant, Mayumi Yamamoto, Nicholas M Dean, Jacqueline R Wyatt, Konrad Mebert, James E Watson, Denise R Cooper.   

Abstract

Previous studies showed that short term exposure of cells to high glucose destabilized protein kinase C (PKC) betaII mRNA, whereas PKCbetaI mRNA levels remained unaltered. Because PKCbeta mRNAs share common sequences other than the PKCbetaII exon encoding a different carboxyl terminus, we examined PKCbetaII mRNA for a cis-acting region that could confer glucose-induced destabilization. A beta-globin/growth hormone reporter con struct containing the PKCbetaII exon was transfected into human aorta and rat vascular smooth muscle cells (A10) to follow glucose-induced destabilization. Glucose (25 mm) exposure destabilized PKCbetaII chimeric mRNA but not control mRNA. Deletion analysis and electrophoretic mobility shift assays followed by UV cross-linking experiments demonstrated that a region introduced by inclusion of the betaII exon was required to confer destabilization. Although a cis-acting element mapped to 38 nucleotides within the betaII exon was necessary to bestow destabilization, it was not sufficient by itself to confer complete mRNA destabilization. Yet, in intact cells antisense oligonucleotides complementary to this region blocked glucose-induced destabilization. These results suggest that this region must function in context with other sequence elements created by exon inclusion involved in affecting mRNA stability. In summary, inclusion of an exon that encodes PKCbetaII mRNA introduces a cis-acting region that confers destabilization to the mRNA in response to glucose.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407109     DOI: 10.1074/jbc.M206797200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Specific protein kinase C isoforms as transducers and modulators of insulin signaling.

Authors:  Sanford R Sampson; Denise R Cooper
Journal:  Mol Genet Metab       Date:  2006-06-23       Impact factor: 4.797

2.  hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing.

Authors:  Rachel Wilson Goehe; Jacqueline C Shultz; Charuta Murudkar; Sanja Usanovic; Nadia F Lamour; Davis H Massey; Lian Zhang; D Ross Camidge; Jerry W Shay; John D Minna; Charles E Chalfant
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

3.  Vitamin A metabolite, all-trans-retinoic acid, mediates alternative splicing of protein kinase C deltaVIII (PKCdeltaVIII) isoform via splicing factor SC35.

Authors:  Hercules Apostolatos; André Apostolatos; Timothy Vickers; James E Watson; Shijie Song; Fernando Vale; Denise R Cooper; Juan Sanchez-Ramos; Niketa A Patel
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

4.  Tra2beta as a novel mediator of vascular smooth muscle diversification.

Authors:  Supriya Shukla; Steven A Fisher
Journal:  Circ Res       Date:  2008-07-31       Impact factor: 17.367

Review 5.  Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase C beta II expression.

Authors:  Matthew R Farren; Louise M Carlson; Kelvin P Lee
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

6.  High glucose-induced Nox1-derived superoxides downregulate PKC-betaII, which subsequently decreases ACE2 expression and ANG(1-7) formation in rat VSMCs.

Authors:  Eduard N Lavrentyev; Kafait U Malik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-31       Impact factor: 4.733

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.